Omron Adept Technologies, Inc. is a global, leading provider of intelligent vision-guided robotics systems and services.. Joining Omron Corpration in October 2015, Adept is now a part of the acceleration of OMRON's "ILOR+S" (Input, Logic, Output, Robotics and Safety) strategy for its Industrial Automation Business, which provides automation solutions for the manufacturing industries Adept systems provide unmatched performance and economic value throughout the production lifecycle, enabling customers to achieve precision, quality and productivity in their assembly, handling and packaging processes.
Founded in 1983, Omron Adept Technologies is the largest U.S.-based manufacturer of industrial robots. Adept intelligent automation product lines include industrial robots, mobile robots, and other flexible automation equipment, machine vision, and systems and applications software. Omron Adept provides cost-effective robotics systems and services to high-growth markets including Packaged Goods, Life Sciences, Electronics and Semiconductor; as well as to traditional industrial markets including machine tool automation and automotive components.
Manufacturing its products in San Ramon, California, Omron Adept markets, distributes, and supports its products worldwide both directly and through channel partners. Adept’s robotics products and services are the solutions of choice for many industry-leading corporations. Adept is ISO 9001:2000 certified.
Omron Adept believes intelligent automation is key to the success of any medium or high volume discrete manufacturing enterprise. Omron Adept's strategy is to provide a broad range of high reliability, configurable, intelligent robot, controller, vision and software products along with world-class service to allow manufacturers to maximize the productivity, flexibility and quality of the products they manufacture.
Each year, millions of people hear the words no one wants to hear: "You have cancer." And behind each diagnosis lies a unique story, a family that deserves hope, a future that's worth fighting for. We know that no two treatment journeys are the same and delivering care is far from simple. It's complex, urgent, and deeply human. That’s why we don’t back down from challenges—we rise to them. From the smallest tumor change to the toughest clinical decisions, we see every obstacle as an opportunity to progress. That is what drives us. The people undergoing treatment. The clinicians providing the care. We are united in purpose. Together, we can create a world where every patient has access to the highest standard of care. This is our commitment because for everyone, it's personal. We are leading the innovation in personalized radiation therapy solutions. We are Elekta.
Elekta reserves the right to remove any comment and to restrict access to its page at its sole discretion, without prior notice. The presence of user comments does not imply endorsement by Elekta, and Elekta makes no representations regarding the accuracy of such comments. User-generated content does not necessarily reflect the views, values, or positions of Elekta.
Molecular Devices is one of the world’s leading providers of high-performance life science technology. We make advanced scientific discovery possible for academia, pharma, and biotech customers with platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection.
From cancer to COVID-19, we've contributed to scientific breakthroughs described in over 230,000 peer-reviewed publications. Over 160,000 of our innovative solutions are incorporated into laboratories worldwide, enabling scientists to improve productivity and effectiveness – ultimately accelerating research and the development of new therapeutics.
Molecular Devices is headquartered in Silicon Valley, Calif., with best-in-class teams around the globe. Over 1,000 associates are guided by our diverse leadership team and female president that prioritize a culture of collaboration, engagement, diversity, and inclusion.
Molecular Devices is proud to be part of Danaher, a global life sciences and diagnostics innovator committed to accelerating the power of science and technology to improve human health.
As part of Danaher, Molecular Devices is connected to a uniquely broad ecosystem of expertise, technologies, and capabilities. Together, we partner closely with customers to help solve their toughest challenges with greater speed and certainty.
Powered by the Danaher Business System, our advanced science and technology and proven ability to innovate help enable faster, more accurate diagnoses and reduce the time, cost, and risk required to discover, develop, and deliver life-changing therapies. Through continuous improvement and operational excellence, our approximately 60,000 associates worldwide are focused on delivering lasting impact and improving quality of life around the world, while building a healthier, more sustainable tomorrow.
To learn more about how Molecular Devices helps fast-track scientific discovery, visit www.moleculardevices.com.